香港骨质疏松症的管理
Management of osteoporosis in Hong Kong.
作者信息
Kung Annie W C
机构信息
Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong.
出版信息
Clin Calcium. 2004 Sep;14(9):108-11.
PMID:15577121
Abstract
Osteoporosis is among the top 3 medical conditions that are associated with greatest morbidity and reduction of quality of life of Hong Kong elderly subjects. The genetic and environmental risk factors for osteoporosis in southern Chinese as well as the current approach towards managing this growing health problem in Hong Kong are presented.
摘要
骨质疏松症是与香港老年人群发病率最高和生活质量下降相关的三大疾病之一。本文介绍了中国南方人群骨质疏松症的遗传和环境风险因素，以及香港目前对这一日益严重的健康问题的管理方法。
相似文献
1
Management of osteoporosis in Hong Kong.
Clin Calcium. 2004 Sep;14(9):108-11.
2
[Role of estrogen and selective estrogen receptor modulators in anti-aging].
Clin Calcium. 2008 Jul;18(7):986-94.
3
[Osteoporosis].
Duodecim. 2000;116(16):1772-88.
4
Osteoporosis: primary prevention in the community.
Med J Malaysia. 2007 Oct;62(4):355-7; quiz 358.
5
[Public health. Prevention of osteoporosis in the elderly].
Soins Gerontol. 2001 Oct(31):22-7.
6
Osteoporosis: detection, prevention, and treatment in primary care.
Geriatrics. 1998 Aug;53(8):22-3, 27-8, 33 passim.
7
[Treatment of osteoporosis].
Orv Hetil. 2003 Aug 3;144(31):1551-2.
8
[From effective to economical. The value of good osteoporosis therapy].
MMW Fortschr Med. 2002 May 23;144(21):30-3.
9
NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy, March 7-29, 2000: highlights of the conference.
South Med J. 2001 Jun;94(6):569-73.
10
[The necessity of cost-effectiveness analysis in osteoporosis].
Rev Med Suisse. 2007 Jun 13;3(115):1521-5.
引用本文的文献
1
The Chinese skeleton: insights into microstructure that help to explain the epidemiology of fracture.
Bone Res. 2014 Jun 10;2:14009. doi: 10.1038/boneres.2014.9. eCollection 2014.
Zotero 插件